Seasonal Influenza: Competitive Landscape to 2026 [Report Updated: 08112018] Prices from USD $2971

05:22 EST 6 Dec 2018 | BioPortfolio Reports

Seasonal Influenza: Competitive Landscape to 2026


Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The influenza A H1N1 and H3N2, and influenza B strains are those responsible for seasonal influenza infections. The symptoms of influenza are similar to those of the common cold, though they are usually more severe, have a sudden onset, last for one to two weeks, and are normally selflimiting without medical treatment. The very young, elderly, and patients with chronic illness such as diabetes, asthma, or cardiovascular disease are most at risk of complications due to influenza.

This report provides an assessment of the pipeline, clinical, and commercial landscape of seasonal influenza. Overall, GlobalData expects new drug approvals to drive a shift in the treatment and prophylaxis of seasonal influenza over the next decade 20162026.


This report combines data from the Pharma Intelligence Center with inhouse analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include

Pipeline Assessment: regional breakdown, promising latestage products, earlystage pipeline by product type

Clinical Trials Assessment: trial breakdown by phase, leading industry and nonindustry sponsors, enrollment analytics

Commercial Assessment: leading marketed products, current and future players

Competitive Landscape Analysis: key market events 20162026.

Reasons to buy

Develop and design your inlicensing and outlicensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global seasonal influenza market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global seasonal influenza market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Original Article: Seasonal Influenza: Competitive Landscape to 2026 [Report Updated: 08112018] Prices from USD $2971


More From BioPortfolio on "Seasonal Influenza: Competitive Landscape to 2026 [Report Updated: 08112018] Prices from USD $2971"

Quick Search


Relevant Topics

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...